Genome News and Research

RSS
TGen deploys Isilon IQ to power multiple genome sequencing devices to discover new treatments for diseases

TGen deploys Isilon IQ to power multiple genome sequencing devices to discover new treatments for diseases

Study validates Chronix Biomedical’s serum DNA blood tests for early, accurate detection of breast cancer

Study validates Chronix Biomedical’s serum DNA blood tests for early, accurate detection of breast cancer

USF study: HHV-6 causes permanent infection by inserting its DNA into human chromosomes

USF study: HHV-6 causes permanent infection by inserting its DNA into human chromosomes

IEEE, AMA to host conference: Overcoming challenges in individualized healthcare, technological innovations

IEEE, AMA to host conference: Overcoming challenges in individualized healthcare, technological innovations

RDS launches international outreach program on cognitive impairment in Down syndrome patients

RDS launches international outreach program on cognitive impairment in Down syndrome patients

Fluidigm's Access Array System: New 5kb and 10kb long-range PCR protocols introduced

Fluidigm's Access Array System: New 5kb and 10kb long-range PCR protocols introduced

Scientists identify  EoE-associated region in human chromosome

Scientists identify EoE-associated region in human chromosome

Pediatrics researchers identify major gene location responsible for EoE

Pediatrics researchers identify major gene location responsible for EoE

Researchers discuss possibility of using food to prevent individual's genes from expressing disease

Researchers discuss possibility of using food to prevent individual's genes from expressing disease

Scientists succeed in mapping entire network of DNA-binding transcription factors

Scientists succeed in mapping entire network of DNA-binding transcription factors

Life Technologies, TGen, US Oncology collaborate to sequence genomes of triple negative breast cancer patients

Life Technologies, TGen, US Oncology collaborate to sequence genomes of triple negative breast cancer patients

Tax treaty with U.S. will pave way for investment in Canadian biotechnology firms, says BIOTECanada

Tax treaty with U.S. will pave way for investment in Canadian biotechnology firms, says BIOTECanada

Gene involved in susceptibility and resistance to TB identified

Gene involved in susceptibility and resistance to TB identified

Lemelson-MIT Collegiate Student Prizes awarded to inventive students nationwide

Lemelson-MIT Collegiate Student Prizes awarded to inventive students nationwide

Affymetrix introduces GeneAtlas System for processing arrays and characterizing changes in gene expression

Affymetrix introduces GeneAtlas System for processing arrays and characterizing changes in gene expression

Supercomputer receives powerful supercomputer for biomedical and life sciences research from IBM

Supercomputer receives powerful supercomputer for biomedical and life sciences research from IBM

Most strains of pandemic H1N1 flu virus resist Tamiflu, say scientists

Most strains of pandemic H1N1 flu virus resist Tamiflu, say scientists

Sigma-Aldrich unveils new Sigma Life Science brand and website platform

Sigma-Aldrich unveils new Sigma Life Science brand and website platform

Life Technologies announces early stage results from SMS technology

Life Technologies announces early stage results from SMS technology

Gene research offers new hope for targeted breast cancer treatment

Gene research offers new hope for targeted breast cancer treatment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.